Ontology-based prediction of cancer driver genes

Autor: Ashraf Dallol, Georgios V. Gkoutos, Rolina Al-Wassia, Shadi S. Alkhayyat, Sara Althubaiti, Robert Hoehndorf, Takashi Gojobori, Katsuhiko Mineta, Paul N. Schofield, Andrew D Beggs, Adeeb Noor, Andreas Karwath
Přispěvatelé: Althubaiti, Sara [0000-0001-5754-8569], Dallol, Ashraf [0000-0002-8803-228X], Mineta, Katsuhiko [0000-0002-4727-045X], Beggs, Andrew D [0000-0003-0784-2967], Schofield, Paul N [0000-0002-5111-7263], Hoehndorf, Robert [0000-0001-8149-5890], Apollo - University of Cambridge Repository, Beggs, Andrew D. [0000-0003-0784-2967], Schofield, Paul N. [0000-0002-5111-7263]
Rok vydání: 2019
Předmět:
Colorectal cancer
lcsh:Medicine
02 engineering and technology
medicine.disease_cause
Machine Learning
0302 clinical medicine
Neoplasms
Exome
lcsh:Science
Cancer genetics
0303 health sciences
Mutation
Multidisciplinary
article
High-Throughput Nucleotide Sequencing
Genomics
Phenotype
3. Good health
030220 oncology & carcinogenesis
Identification (biology)
139
141
0206 medical engineering
631/114/2403
Computational biology
Biology
03 medical and health sciences
Biomarkers
Tumor

medicine
Humans
Genetic Predisposition to Disease
Gene
Genetic Association Studies
030304 developmental biology
Whole genome sequencing
Genetic heterogeneity
lcsh:R
Computational Biology
Cancer
Molecular Sequence Annotation
Oncogenes
631/114/1305
medicine.disease
Gene Ontology
692/4028/67/68
ROC Curve
lcsh:Q
119
human activities
020602 bioinformatics
Zdroj: Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports
ISSN: 2045-2322
DOI: 10.1038/s41598-019-53454-1
Popis: Identifying and distinguishing cancer driver genes among thousands of candidate mutations remains a major challenge. Accurate identification of driver genes and driver mutations is critical for advancing cancer research and personalizing treatment based on accurate stratification of patients. Due to inter-tumor genetic heterogeneity, many driver mutations within a gene occur at low frequencies, which make it challenging to distinguish them from non-driver mutations. We have developed a novel method for identifying cancer driver genes. Our approach utilizes multiple complementary types of information, specifically cellular phenotypes, cellular locations, functions, and whole body physiological phenotypes as features. We demonstrate that our method can accurately identify known cancer driver genes and distinguish between their role in different types of cancer. In addition to confirming known driver genes, we identify several novel candidate driver genes. We demonstrate the utility of our method by validating its predictions in nasopharyngeal cancer and colorectal cancer using whole exome and whole genome sequencing.
Databáze: OpenAIRE